Home › NDC Lookup › RxCUI directory › RxCUI 1545666

Empagliflozin 25 MG Oral Tablet — RxCUI 1545666

RxNorm drug concept · Semantic clinical drug
RxCUI 1545666 Semantic clinical drug · SCD ● Current RxNorm concept 7 FDA products 19 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1545666
Official nameEmpagliflozin 25 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped7
Package NDCs mapped19
Reported Medicaid activity (SDUD)2,905,773 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Empagliflozin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Jardiance does much more than just lower blood sugar. Yes, it's approved to help control blood sugar in type 2 diabetes — but it's also proven to reduce serious risks in heart fail...
  • What exactly does Jardiance do — is it just for blood sugar?
  • That's completely expected. Jardiance works by causing your kidneys to release excess glucose through your urine, and extra fluid follows along with it. This is actually part of ho...
  • Why am I urinating more often since starting this medication?
📖 Read our full Empagliflozin guide →

🕸️ Concept Web — How Empagliflozin 25 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Empagliflozin 25 MG Oral Tablet RxCUI 1545666

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Empagliflozin 1545653
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Jardiance 1545659
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Empagliflozin Oral Tablet 1545657
    • Empagliflozin Oral Product 1545655
    • Empagliflozin Pill 1545656
    • Empagliflozin Oral Tablet [Jardiance] 1545661
    • Jardiance Oral Product 1545662
    • Jardiance Pill 1545663
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Empagliflozin 25 MG SCDC · 1545665
  • Empagliflozin Oral Tablet SCDF · 1545657
  • Empagliflozin Oral Product SCDG · 1545655
  • Empagliflozin Pill SCDG · 1545656

Brand-Name Concepts

  • Empagliflozin 25 MG Oral Tablet [Jardiance] SBD · 1545668
  • Empagliflozin 25 MG [Jardiance] SBDC · 1545667
  • Empagliflozin Oral Tablet [Jardiance] SBDF · 1545661
  • Jardiance Oral Product SBDG · 1545662
  • Jardiance Pill SBDG · 1545663
  • Jardiance BN · 1545659

📦 FDA Products & Package NDCs

7 products · 19 package NDCs
19 package NDCs map to RxCUI 1545666 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00597-0152-07 1 BOTTLE in 1 CARTON (0597-0152-07) / 7 TABLET, FILM COATED... Jardiance Boehringer Ingelheim Pharmaceuticals, Inc. 2014-08-01
00597-0152-30 30 TABLET, FILM COATED in 1 BOTTLE (0597-0152-30) Jardiance Boehringer Ingelheim Pharmaceuticals, Inc. 2014-08-01
00597-0152-37 30 BLISTER PACK in 1 CARTON (0597-0152-37) / 1 TABLET, FILM... Jardiance Boehringer Ingelheim Pharmaceuticals, Inc. 2014-08-01
00597-0152-90 90 TABLET, FILM COATED in 1 BOTTLE (0597-0152-90) Jardiance Boehringer Ingelheim Pharmaceuticals, Inc. 2014-08-01
00597-0153-07 1 BOTTLE in 1 CARTON (0597-0153-07) / 7 TABLET, FILM COATED... Jardiance Boehringer Ingelheim Pharmaceuticals, Inc. 2014-08-01
00597-0153-30 30 TABLET, FILM COATED in 1 BOTTLE (0597-0153-30) Jardiance Boehringer Ingelheim Pharmaceuticals, Inc. 2014-08-01
00597-0153-37 30 BLISTER PACK in 1 CARTON (0597-0153-37) / 1 TABLET, FILM... Jardiance Boehringer Ingelheim Pharmaceuticals, Inc. 2014-08-01
00597-0153-90 90 TABLET, FILM COATED in 1 BOTTLE (0597-0153-90) Jardiance Boehringer Ingelheim Pharmaceuticals, Inc. 2014-08-01
50090-4384-00 90 TABLET, FILM COATED in 1 BOTTLE (50090-4384-0) Jardiance A-S Medication Solutions 2019-06-25
50090-4384-01 30 TABLET, FILM COATED in 1 BOTTLE (50090-4384-1) Jardiance A-S Medication Solutions 2023-08-06
50090-6457-00 90 TABLET, FILM COATED in 1 BOTTLE (50090-6457-0) JARDIANCE A-S Medication Solutions 2023-05-01
55154-0411-08 720 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55154-0411-8) Jardiance Cardinal Health 107, LLC 2014-08-01
55154-0412-08 990 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55154-0412-8) Jardiance Cardinal Health 107, LLC 2014-08-01
71610-0177-09 9000 TABLET, FILM COATED in 1 BOTTLE (71610-177-09) Jardiance Aphena Pharma Solutions - Tennessee, LLC 2018-10-24
71610-0177-15 15 TABLET, FILM COATED in 1 BOTTLE (71610-177-15) Jardiance Aphena Pharma Solutions - Tennessee, LLC 2019-09-18
71610-0177-42 1800 TABLET, FILM COATED in 1 BOTTLE (71610-177-42) Jardiance Aphena Pharma Solutions - Tennessee, LLC 2022-12-09
71610-0177-45 45 TABLET, FILM COATED in 1 BOTTLE (71610-177-45) Jardiance Aphena Pharma Solutions - Tennessee, LLC 2019-10-03
71610-0177-81 1080 TABLET, FILM COATED in 1 BOTTLE (71610-177-81) Jardiance Aphena Pharma Solutions - Tennessee, LLC 2025-04-22
71610-0177-99 5040 TABLET, FILM COATED in 1 BOTTLE (71610-177-99) Jardiance Aphena Pharma Solutions - Tennessee, LLC 2025-10-27
Observed labelers: Boehringer Ingelheim Pharmaceuticals, Inc. (8) · Aphena Pharma Solutions - Tennessee, LLC (6) · A-S Medication Solutions (3) · Cardinal Health 107, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.